HIV treatment and prevention on every 2026 Puerto Rico Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 3 stand-alone Part D plans in Puerto Rico cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | HealthSpring Extra Rx$50.00/moS5617-385 | HealthSpring Assurance Rx$65.70/moS5617-348 | AARP Medicare Rx Preferred from UHC$145.10/moS5820-037 |
|---|---|---|---|
| Biktarvybictegravir/emtricitabine/tenofovir alafenamide | Tier 525% | Tier 525% | Tier 525%QL 30/30d |
| Dovatodolutegravir and lamivudine | Tier 525% | Tier 525% | Tier 525%QL 30/30d |
| Triumeqabacavir/dolutegravir/lamivudine | Tier 431%QL 300/30d | Tier 434%QL 300/30d | Tier 425%QL 180/30d |
| Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525%QL 30/30d |
| Odefseyemtricitabine/rilpivirine/tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525%QL 30/30d |
| Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamide | Tier 525% | Tier 525% | Tier 525%QL 30/30d |
| Julucadolutegravir and rilpivirine | Tier 525% | Tier 525% | Tier 525%QL 30/30d |
| Descovyemtricitabine and tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525%QL 30/30d |
| Truvadaemtricitabine and tenofovir disoproxil | Not covered | Not covered | Not covered |
| emtricitabine-tenofovirgeneric Truvada | Tier 431%QL 30/30d | Tier 434%QL 30/30d | Tier 425%QL 30/30d |
| Tivicaydolutegravir | Tier 431%QL 180/30d | Tier 434%QL 180/30d | Tier 525%QL 60/30d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.